Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents

Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents

Abstract Background Studies on temporal changes in noninvasive fibrosis indices and liver stiffness measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting antiviral agents (DAAs) are limited. Methods We retrospectively enrolled consecutive patients with CHC who had r...

Full description

Bibliographic Details
Main Authors: Wei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Hung-Yao Chen, Hung-Wei Wang, Guan-Tarn Huang, Cheng-Yuan Peng
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Gastroenterology
Subjects:
Aspartate aminotransferase/platelet ratio index (APRI)
Chronic hepatitis C
Direct-acting antiviral agents
FIB-4
Liver stiffness measurement
Noninvasive fibrosis index
Online Access:http://link.springer.com/article/10.1186/s12876-019-0973-5

Internet

http://link.springer.com/article/10.1186/s12876-019-0973-5

Similar Items